Sanofi Aventis counter sues against Ypsomed in patent infringement case |
|
|
|
Published
:
Thu, 18 Oct 2007 11:24
|
ZURICH (Thomson Financial) - Ypsomed Holding AG said that Sanofi-Aventis has filed a lawsuit in Basel against Ypsomed, claiming 'certain license rights' to the insulin injection system SoloStar.The move comes in the wake of a patent infringement lawsuit that Ypsomed launched against Sanofi in Germany on Aug 27, 2007.'The lawsuit claims certain license rights, which in the opinion of Sanofi-Aventis should be granted by Ypsomed,' said Ypsomed in a statement.Ypsomed is convinced that Sanofi-Aventis has no legal titles in this respect and 'clearly contests the claims', added the statement.Sanofi-Aventis remains Ypsomed's main customer, and continues to place orders that are 'within expectations but lower than in the past year', the Swiss group said recently.sarah.fenwick@thomson.comat/sf/cmrCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
|
|
Print this Story
Judge may overturn Qualcomm ruling 